SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Drug Development
Genentech R&D Exec Reveals Alzheimer’s is Still A Priority
July 19, 2017
 · 
1 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech’s Hemophilia Blockbuster Contender Hits Phase III Goals, But Questions Remain
June 26, 2017
 · 
2 min read
Job Trends
Genentech Wins No. 1 Top Spot as The Ideal Employer in Life Sciences
“Who do you most want to work for?” That’s what BioSpace asked 2,440 life sciences professionals in its first annual Ideal Employer survey.
June 22, 2017
 · 
4 min read
NewLink Stock Plunges After Genentech Bails on $1 Billion+ IDO
Business
NewLink Genetics Stock Plunges After Genentech Bails on $1 Billion+ IDO Deal
June 8, 2017
 · 
3 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech Shares Jump
June 6, 2017
 · 
3 min read
What a Day! Genentech Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis
Biotech Bay
Genentech Will Pass Out More Cash to Researchers to Stand Up to Cancer
May 18, 2017
 · 
2 min read
Business
How Genentech Could Be A New Threat For Biogen
May 10, 2017
 · 
1 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech’s Top Cancer Prospect Flunks Phase III Test
May 10, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Business
Genentech Exec Jumps Ship to Become CMO at Gritstone Oncology
May 3, 2017
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
FDA
Genentech Announces FDA Grants Venclexta (Venetoclax) Accelerated Approval For People With A Hard-To-Treat Type Of Chronic Lymphocytic Leukemia
April 12, 2016
 · 
11 min read
FDA
FDA Green Lights AbbVie, Genentech’s New Chronic Lymphocytic Leukemia Drug Venclexta
April 11, 2016
 · 
3 min read
Policy
FDA Accepts Genentech’s BLA and Grants Priority Review for Lung Cancer Drug Atezolizumab
April 11, 2016
 · 
4 min read
Business
SoCal’s Kite Pharma Grabs a Clinical Trial Cancer Deal with Genentech
March 17, 2016
 · 
1 min read
Policy
FDA Files Genentech’s Supplemental Biologics License Application Of Xolair (Omalizumab) For Pediatric Allergic Asthma
March 1, 2016
 · 
9 min read
Drug Development
Genentech Provides Update On Two Identical Phase Iii Studies Of Lebrikizumab In People With Severe Asthma
February 29, 2016
 · 
4 min read
FDA
FDA Green Lights Genentech’s Gazyva for Patients with Previously Treated Follicular Lymphoma
February 26, 2016
 · 
17 min read
Drug Development
FDA Grants Breakthrough Therapy Designation For Genentech’s Investigational Medicine Ocrelizumab In Primary Progressive Multiple Sclerosis
February 17, 2016
 · 
5 min read
Policy
Tennessee Oncology Sues Genentech Over Cancer Drug Herceptin
February 9, 2016
 · 
1 min read
Drug Development
Genentech Sponsored Study Reveals Hidden Stigma of Lung Cancer
January 21, 2016
 · 
3 min read
Load More